Advertisement

Topics

Funding round raises $19M for Locus to develop CRISPR-Cas3 technology

04:26 EST 16 Nov 2017 | SmartBrief

Locus Biosciences plans to use the $19 million it raised from a Series A funding round to develop antimicrobials to combat dr -More

Original Article: Funding round raises $19M for Locus to develop CRISPR-Cas3 technology

NEXT ARTICLE

More From BioPortfolio on "Funding round raises $19M for Locus to develop CRISPR-Cas3 technology"

Advertisement
Quick Search
Advertisement
Advertisement